Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17077-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17077-1-AP, RRID:AB_2715526
- Product name
- PIP4K2C antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PIP4K2C antibody (Cat. #17077-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A proximity-labeling map of PI5P4K phosphoinositide kinases interaction networks.
Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer.
Traditional wisdom meets modern science: The protective role of sanhuang shu'ai decoction in ulcerative colitis models.
Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion.
Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration.
PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism.
Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.
Llorente A, Arora GK, Loughran RM, Murad R, Maurya S, Crabtree S, Portillo B, Chapagain P, Huluka H, Eron S, Goodman K, Ye G, Blind RD, Emerling BM
The Journal of biological chemistry 2026 Apr 24;:113071
The Journal of biological chemistry 2026 Apr 24;:113071
Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer.
Xiong L, Tang 唐磊 L, Zhao W, Wang R, Cheng C, Wang D, Xu Y, Tang 汤磊 L, Fan Y
Journal of advanced research 2025 Sep 22;
Journal of advanced research 2025 Sep 22;
Traditional wisdom meets modern science: The protective role of sanhuang shu'ai decoction in ulcerative colitis models.
Zhang N, Liu A, Cao M, Han Z, Guo D, Zhang S, Zhang J
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Nov;147:157163
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Nov;147:157163
Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion.
Jin Y, Xue J, Li X, Zhong X
Translational oncology 2025 Jul;57:102420
Translational oncology 2025 Jul;57:102420
Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration.
Benyair R, Giridharan SSP, Rivero-Ríos P, Hasegawa J, Bristow E, Eskelinen EL, Shmueli MD, Fishbain-Yoskovitz V, Merbl Y, Sharkey LM, Paulson HL, Hanson PI, Patnaik S, Al-Ramahi I, Botas J, Marugan J, Weisman LS
Autophagy reports 2023;2(1)
Autophagy reports 2023;2(1)
PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism.
Wang DG, Paddock MN, Lundquist MR, Sun JY, Mashadova O, Amadiume S, Bumpus TW, Hodakoski C, Hopkins BD, Fine M, Hill A, Yang TJ, Baskin JM, Dow LE, Cantley LC
Cell reports 2019 May 14;27(7):1991-2001.e5
Cell reports 2019 May 14;27(7):1991-2001.e5
Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.
Al-Ramahi I, Giridharan SSP, Chen YC, Patnaik S, Safren N, Hasegawa J, de Haro M, Wagner Gee AK, Titus SA, Jeong H, Clarke J, Krainc D, Zheng W, Irvine RF, Barmada S, Ferrer M, Southall N, Weisman LS, Botas J, Marugan JJ
eLife 2017 Dec 26;6
eLife 2017 Dec 26;6
No comments: Submit comment
No validations: Submit validation data